262
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Metabonomic profiling of diet-induced hyperlipidaemia in a rat model

, , , , , & show all
Pages 205-216 | Received 23 Aug 2009, Accepted 15 Oct 2009, Published online: 09 Dec 2009

References

  • A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T. (2005). Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 77:8086–94.
  • Alwaili K, Alrasadi K, Awan Z, Genest J. (2009). Approach to the diagnosis and management of lipoprotein disorders. Curr Opin Endocrinol Diabetes Obes 16:132–40.
  • Denkert C.(2008). (Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer). Pathologe 29 (Suppl. 2):168–71.
  • Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S. (2004). Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem 380:419–29.
  • Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. (2001). Multi- and Megavariate Data Analysis principles and Applications. Umeå: Umetrics Academy.
  • Giovane A, Balestrieri A, Napoli C. (2008). New insights into cardiovascular and lipid metabolomics. J Cell Biochem 105:648–54.
  • Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM. (2006). Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113:647–56.
  • Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. (2008). Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 8:617–33.
  • Griffin JL. (2003). Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr Opin Chem Biol 7:648–54.
  • Holmes E, Wilson ID, Nicholson JK. (2008). Metabolic phenotyping in health and disease. Cell 134:714–17.
  • Jonsson P, Bruce SJ, Moritz T, Trygg J, Sjostrom M, Plumb R, Granger J, Maibaum E, Nicholson JK, Holmes E and others. (2005a). Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst 130:701–7.
  • Jonsson P, Johansson AI, Gullberg J, Trygg J, A J, Grung B, Marklund S, Sjostrom M, Antti H, Moritz T. (2005b). High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 77:5635–42.
  • Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ, Zhou J, Somel M, Harris LW, Holmes E and others. (2008). Metabolic changes in schizophrenia and human brain evolution. Genome Biol 9:R124.
  • Lahoz C, Mostaza JM. (2007). (Atherosclerosis as a systemic disease). Rev Esp Cardiol 60:184–95.
  • LaRosa JC. (2001). Prevention and treatment of coronary heart disease: who benefits? Circulation 104:1688–92.
  • Lewis GD, Asnani A, Gerszten RE. (2008). Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 52:117–23.
  • Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. (2004a). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9:1–31.
  • Lindon JC, Holmes E, Nicholson JK. (2004b). Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 4:189–99.
  • Lindon JC, Holmes E, Nicholson JK. (2004c). Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 6:265–72.
  • Nagaraj NS. (2009). Evolving ‘omics’ technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic 8:49–59.
  • Nicholson JK, Holmes E, Elliott P. (2008). The metabolome-wide association study: a new look at human disease risk factors. J Proteome Res 7:3637–8.
  • Nicholson JK, Lindon JC. (2008). Systems biology: metabonomics. Nature 455:1054–6.
  • Nordstrom A, Lewensohn R. (2009). Metabolomics: moving to the clinic. J Neuroimmune Pharmacol [April 28: Epub ahead of print.]
  • O’Keefe JH, Bell DS. (2007). Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100:899–904.
  • Raal FJ. (2009). Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord 7:83–8.
  • Rosenson RS. (2008). Biomarkers, atherosclerosis and cardiovascular events. Expert Rev Cardiovasc Ther 6:619–22.
  • Spratlin JL, Serkova NJ, Eckhardt SG. (2009). Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431–40.
  • Tannock LR. (2008). Advances in the management of hyperlipidemia-induced atherosclerosis. Expert Rev Cardiovasc Ther 6:369–83.
  • Trygg J, Holmes E, Lundstedt T. (2007). Chemometrics in metabonomics. J Proteome Res 6:469–79.
  • Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S and others. (2007). HMDB: the Human Metabolome Database. Nucleic Acids Res 35:D521-6.
  • Xu S-Y, Bian R-L, Chen X. (2003). Chapter 8: Methodology of pharmacology experiments in cardiovascular systems. In: Methodology of Pharmacology Experiments, 3rd edn. Beijing: People’s Medical Publishing House. p. 1189–296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.